Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

RAS Mutations in Colorectal Cancer

27 Nov 2013

Abstract excerpt

mu-tations in exon 2 could predict a lack of response in patients who received panitumumab plus oxali -platin, fluorouracil, and leucovorin (FOLFOX4) for the treatment of metastatic colorectal cancer. The grade of rash in patients who received an anti–epidermal growth factor receptor antibody has been strongly associated with clinical out-come, even in patients who have

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal and Anal Carcinomas
Share to Colorectal Cancer Treatments and Studies
Share to Genetic factors in colorectal cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24283232
DOI: 10.1056/nejmc1312697

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

RAS Mutations in Colorectal CancerPMID 24283232Read ↗

RAS genes in colorectal carcinoma: pathogenesis, testing guidelines and treatment implicationsSemantic proximity Read ↗

Limited Efficacy of Anti-EGFR Monoclonal Antibodies in Colorectal Cancer Patients with Rare RAS Variants: Analysis of the C-CAT DatabaseSemantic proximity Read ↗

Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015 Summary.Semantic proximity Read ↗

Association between clinicopathological characteristics and RAS mutation in colorectal cancer.Semantic proximity Read ↗

Impact of the evolution in RAS mutation analysis in Australian patients with metastatic colorectal cancer.Semantic proximity Read ↗

BRAF Mutations in Colorectal Cancer: Clinical Relevance and Role in Targeted TherapySemantic proximity Read ↗

Ras in digestive oncology: from molecular biology to clinical implications.Semantic proximity Read ↗

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer.Semantic proximity Read ↗

Extended RAS analysis for anti-epidermal growth factor therapy in patients with metastatic colorectal cancer.Semantic proximity Read ↗

RAS mutations that have a major impact on current cancer genomic medicineSemantic proximity Read ↗

KRAS Mutations and Susceptibility to Cetuximab and Panitumumab in Colorectal CancerSemantic proximity Read ↗

Japanese Society of Medical Oncology Clinical Guidelines: RAS (KRAS/NRAS) mutation testing in colorectal cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.